Eisbach Bio: Funding, Investors & Team (Sep 2026)
Eisbach Bio is a biotech company established in 2019 in Martinsried, Bavaria, that specializes in developing pharmaceuticals to target specific molecular weaknesses in cancer DNA. Their screening and cell-based technologies are used to identify and create cutting-edge inhibitors tailored to combat the vulnerabilities present in specific types of genetically defined tumors.
Eisbach Bio has raised $9.3M across 2 funding rounds on record, the most recent an undisclosed round of $4.8M announced in Nov 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eisbach Bio Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Eisbach Bio Funding Rounds
Eisbach Bio raised $4.5M in an undisclosed round announced in Mar 2024.
8 months later, an undisclosed round of $4.8M was announced in Nov 2024.
Eisbach Bio Founders and Leadership Team
Contact details for the Eisbach Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Eisbach Bio Funding Compared to Other Biotechnology Startups
Eisbach Bio's latest round of $4.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eisbach Bio in Biotechnology and Munich
Companies Similar to Eisbach Bio
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Eisbach Bio Funding FAQs
What does Eisbach Bio do?
Eisbach Bio is a biotech company established in 2019 in Martinsried, Bavaria, that specializes in developing pharmaceuticals to target specific molecular weaknesses in cancer DNA. Their screening and cell-based technologies are used to identify and create cutting-edge inhibitors tailored to combat the vulnerabilities present in specific types of genetically defined tumors.
How much funding has Eisbach Bio raised?
Eisbach Bio has raised $9.3M across 2 rounds on record. The most recent is an undisclosed round of $4.8M announced in Nov 2024.
When did Eisbach Bio last raise funding?
Eisbach Bio's most recent funding round on record is an undisclosed round of $4.8M, announced in Nov 2024.
Who founded Eisbach Bio?
FundedIQ lists Adrian Schomburg (Founder), Andreas Ladurner (Founder) at Eisbach Bio.
Where is Eisbach Bio headquartered?
Eisbach Bio is based in Munich, Bayern, Germany.
How many employees does Eisbach Bio have?
Eisbach Bio is in the 11-50 employee band.
How does Eisbach Bio's funding compare to other Biotechnology startups?
Eisbach Bio's latest round of $4.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Eisbach Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eisbach Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.